Mother and child T cell receptor repertoires: Deep profiling study

Frontiers in Immunology

Volumn 4, Issue DEC, 2013, Pages

  Putintseva, Ekaterina V ^a   Britanova, Olga V ^a   Staroverov, Dmitriy B ^a   Merzlyak, Ekaterina M ^a   Turchaninova, Maria A ^a   Shugay, Mikhail ^a   Bolotin, Dmitriy A ^a   Pogorelyy, Mikhail V ^a   Mamedov, Ilgar Z ^a   Bobrynina, Vlasta ^b   Maschan, Mikhail ^b   Lebedev, Yuri B ^a   Chudakov, Dmitriy M ^a,c  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^b FSI Federal Research and Clinical Center of Children Hematology Oncology and Immunology of Roszdrav   (Russian Federation)

^c MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Autoimmune diseases; Haploidentical transplantation; Maternal fetal exchange; Microchimerism; NGS; Public clonotypes; T cell receptor; TCR repertoires

Indexed keywords

EID: 84892142348     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00463     Document Type: Article

References (62)

1. Zenclussen AC. Adaptive immune responses during pregnancy. Am J Reprod Immunol (2013) 69:291-303. doi:10.1111/aji.12097
2. Nelson JL, Furst DE, Maloney S, Gooley T, Evans PC, Smith A, et al. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet (1998) 351:559-62. doi:10.1016/S0140-6736(97)08357-8
3. Sarkar K, Miller FW. Possible roles and determinants of microchimerism in autoimmune and other disorders. Autoimmun Rev (2004) 3:454-63. doi:10.1016/j.autrev.2004.06.004
4. Lepez T, Vandewoestyne M, Hussain S, Van Nieuwerburgh F, Poppe K, Velkeniers B, et al. Fetal microchimeric cells in blood of women with an autoimmune thyroid disease. PLoS One (2011) 6:e29646. doi:10.1371/journal.pone.0029646
5. Stern M, Ruggeri L, Mancusi A, Bernardo ME, De Angelis C, Bucher C, et al. Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor. Blood (2008) 112:2990-5. doi:10.1182/blood-2008-01-135285
6. Burlingham WJ, Benichou G. Bidirectional alloreactivity: a proposed microchimerism-based solution to the NIMA paradox. Chimerism (2012) 3:29-36. doi:10.4161/chim.21668
7. Jankowska-Gan E, Sheka A, Sollinger HW, Pirsch JD, Hofmann RM, Haynes LD, et al. Pretransplant immune regulation predicts allograft outcome: bidirectional regulation correlates with excellent renal transplant function in living-related donor-recipient pairs. Transplantation (2012) 93:283-90. doi:10.1097/TP.0b013e31823e46a0
8. Robins HS, Campregher PV, Srivastava SK, Wacher A, Turtle CJ, Kahsai O, et al. Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells. Blood (2009) 114:4099-107. doi:10.1182/blood-2009-04-217604
9. Mamedov IZ, Britanova OV, Bolotin DA, Chkalina AV, Staroverov DB, Zvyagin IV, et al. Quantitative tracking of T cell clones after haematopoietic stem cell transplantation. EMBO Mol Med (2011) 3:201-7. doi:10.1002/emmm.201100129
10. Nguyen P, Ma J, Pei D, Obert C, Cheng C, Geiger TL. Identification of errors introduced during high throughput sequencing of the T cell receptor repertoire. BMC Genomics (2011) 12:106. doi:10.1186/1471-2164-12-106
11. Warren RL, Freeman JD, Zeng T, Choe G, Munro S, Moore R, et al. Exhaustive T-cell repertoire sequencing of human peripheral blood samples reveals signatures of antigen selection and a directly measured repertoire size of at least 1 million clonotypes. Genome Res (2011) 21:790-7. doi:10.1101/gr.115428.110
12. Bolotin DA, Mamedov IZ, Britanova OV, Zvyagin IV, Shagin D, Ustyugova SV, et al. Next generation sequencing for TCR repertoire profiling: platform-specific features and correction algorithms. Eur J Immunol (2012) 42:3073-83. doi:10.1002/eji.201242517
13. Venturi V, Price DA, Douek DC, Davenport MP. The molecular basis for public T-cell responses? Nat Rev Immunol (2008) 8:231-8. doi:10.1038/nri2260
14. Robins HS, Srivastava SK, Campregher PV, Turtle CJ, Andriesen J, Riddell SR, et al. Overlap and effective size of the human CD8+ T cell receptor repertoire. Sci Transl Med (2010) 2:47ra64. doi:10.1126/scitranslmed.3001442
15. Venturi V, Quigley MF, Greenaway HY, Ng PC, Ende ZS, McIntosh T, et al. A mechanism for TCR sharing between T cell subsets and individuals revealed by pyrosequencing. J Immunol (2011) 186:4285-94. doi:10.4049/jimmunol.1003898
16. Britanova OV, Bochkova AG, Staroverov DB, Fedorenko DA, Bolotin DA, Mamedov IZ, et al. First autologous hematopoietic SCT for ankylosing spondylitis: a case report and clues to understanding the therapy. Bone Marrow Transplant (2012) 47:1479-81. doi:10.1038/bmt.2012.44
17. Klarenbeek PL, Remmerswaal EB, ten Berge IJ, Doorenspleet ME, Van Schaik BD, Esveldt RE, et al. Deep sequencing of antiviral T-cell responses to HCMV and EBV in humans reveals a stable repertoire that is maintained for many years. PLoS Pathog (2012) 8:e1002889. doi:10.1371/journal.ppat.1002889
18. Mamedov IZ, Britanova OV, Zvyagin IV, Turchaninova MA, Bolotin DA, Putintseva EV, et al. Preparing unbiased T cell receptor and antibody cDNA libraries for the deep next generation sequencing profiling. Front Immunol (2013) 4:456. doi:10.3389/fimmu.2013.00456
19. Nemazee D. Receptor editing in lymphocyte development and central tolerance. Nat Rev Immunol (2006) 6:728-40. doi:10.1038/nri1939
20. Venturi V, Rudd BD, Davenport MP. Specificity, promiscuity, and precursor frequency in immunoreceptors. Curr Opin Immunol (2013) 25(5):639-45. doi:10.1016/j.coi.2013.07.001
21. Douek DC, Betts MR, Brenchley JM, Hill BJ, Ambrozak DR, Ngai KL, et al. A novel approach to the analysis of specificity, clonality, and frequency of HIV-specific T cell responses reveals a potential mechanism for control of viral escape. J Immunol (2002) 168:3099-104.
22. Britanova OV, Staroverov DB, Chkalina AV, Kotlobay AA, Zvezdova ES, Bochkova AG, et al. Single high-dose treatment with glucosaminyl-muramyl dipeptide is ineffective in treating ankylosing spondylitis. Rheumatol Int (2011) 31:1101-3. doi:10.1007/s00296-010-1663-3
23. Lefranc MP, Giudicelli V, Busin C, Malik A, Mougenot I, Dehais P, et al. LIGM-DB/IMGT: an integrated database of Ig and TcR, part of the immunogenetics database. Ann N Y Acad Sci (1995) 764:47-9. doi:10.1111/j.1749-6632.1995.tb55805.x
24. Bolotin DA, Shugay M, Mamedov IZ, Putintseva EV, Turchaninova MA, Zvyagin IV, et al. MiTCR: software for T-cell receptor sequencing data analysis. Nat Methods (2013) 10(9):813-4. doi:10.1038/nmeth.2555
25. Lin JT. Divergence measures based on the Shannon entropy. IEEE Trans Inf Theory (1991) 37:145-51. doi:10.1109/18.61115
26. Wang J, Vock VM, Li S, Olivas OR, Wilkinson MF. A quality control pathway that down-regulates aberrant T-cell receptor (TCR) transcripts by a mechanism requiring UPF2 and translation. J Biol Chem (2002) 277:18489-93. doi:10.1074/jbc.M111781200
27. Bhalla AD, Gudikote JP, Wang J, Chan WK, Chang YF, Olivas OR, et al. Nonsense codons trigger an RNA partitioning shift. J Biol Chem (2009) 284:4062-72. doi:10.1074/jbc.M805193200
28. Favre D, Stoddart CA, Emu B, Hoh R, Martin JN, Hecht FM, et al. HIV disease progression correlates with the generation of dysfunctional naive CD8(low) T cells. Blood (2011) 117:2189-99. doi:10.1182/blood-2010-06-288035
29. Arstila TP, Casrouge A, Baron V, Even J, Kanellopoulos J, Kourilsky P. A direct estimate of the human alphabeta T cell receptor diversity. Science (1999) 286:958-61. doi:10.1126/science.286.5441.958
30. Venturi V, Chin HY, Asher TE, Ladell K, Scheinberg P, Bornstein E, et al. TCR beta-chain sharing in human CD8+ T cell responses to cytomegalovirus and EBV. J Immunol (2008) 181:7853-62.
31. Li H, Ye C, Ji G, Han J. Determinants of public T cell responses. Cell Res (2012) 22:33-42. doi:10.1038/cr.2012.1
32. Li H, Ye C, Ji G, Wu X, Xiang Z, Li Y, et al. Recombinatorial biases and convergent recombination determine interindividual TCRbeta sharing in murine thymocytes. J Immunol (2012) 189:2404-13. doi:10.4049/jimmunol.1102087
33. Hogquist KA, Baldwin TA, Jameson SC. Central tolerance: learning self-control in the thymus. Nat Rev Immunol (2005) 5:772-82. doi:10.1038/nri1707
34. Rudolph MG, Stanfield RL, Wilson IA. How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol (2006) 24:419-66. doi:10.1146/annurev.immunol.23.021704.115658
35. Garcia KC, Adams JJ, Feng D, Ely LK. The molecular basis of TCR germline bias for MHC is surprisingly simple. Nat Immunol (2009) 10:143-7. doi:10.1038/ni.f.219
36. Miles JJ, Douek DC, Price DA. Bias in the alphabeta T-cell repertoire: implications for disease pathogenesis and vaccination. Immunol Cell Biol (2011) 89:375-87. doi:10.1038/icb.2010.139
37. Desai RG, Creger WP. Maternofetal passage of leukocytes and platelets in man. Blood (1963) 21:665-73.
38. Herzenberg LA, Bianchi DW, Schroder J, Cann HM, Iverson GM. Fetal cells in the blood of pregnant women: detection and enrichment by fluorescence-activated cell sorting. Proc Natl Acad Sci U S A (1979) 76:1453-5. doi:10.1073/pnas.76.3.1453
39. Iverson GM, Bianchi DW, Cann HM, Herzenberg LA. Detection and isolation of fetal cells from maternal blood using the flourescence-activated cell sorter (FACS). Prenat Diagn (1981) 1:61-73. doi:10.1002/pd.1970010111
40. Nelson JL. Your cells are my cells. Sci Am (2008) 298:64-71.
41. Adams Waldorf KM, Gammill HS, Lucas J, Aydelotte TM, Leisenring WM, Lambert NC, et al. Dynamic changes in fetal microchimerism in maternal peripheral blood mononuclear cells, CD4+ and CD8+ cells in normal pregnancy. Placenta (2010) 31:589-94. doi:10.1016/j.placenta.2010.04.013
42. Nelson JL. The otherness of self: microchimerism in health and disease. Trends Immunol (2012) 33:421-7. doi:10.1016/j.it.2012.03.002
43. Evans PC, Lambert N, Maloney S, Furst DE, Moore JM, Nelson JL. Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma. Blood (1999) 93:2033-7.
44. Maloney S, Smith A, Furst DE, Myerson D, Rupert K, Evans PC, et al. Microchimerism of maternal origin persists into adult life. J Clin Invest (1999) 104:41-7. doi:10.1172/JCI6611
45. Loubiere LS, Lambert NC, Flinn LJ, Erickson TD, Yan Z, Guthrie KA, et al. Maternal microchimerism in healthy adults in lymphocytes, monocyte/macrophages and NK cells. Lab Invest (2006) 86:1185-92.
46. Gotherstrom C, Johnsson AM, Mattsson J, Papadogiannakis N, Westgren M. Identification of maternal hematopoietic cells in a 2nd-trimester fetus. Fetal Diagn Ther (2005) 20:355-8. doi:10.1159/000086812
47. Khosrotehrani K, Leduc M, Bachy V, Nguyen Huu S, Oster M, Abbas A, et al. Pregnancy allows the transfer and differentiation of fetal lymphoid progenitors into functional T and B cells in mothers. J Immunol (2008) 180: 889-97.
48. Mold JE, Michaelsson J, Burt TD, Muench MO, Beckerman KP, Busch MP, et al. Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science (2008) 322:1562-5. doi:10.1126/science.1164511
49. Murugan A, Mora T, Walczak AM, Callan CG Jr. Statistical inference of the generation probability of T-cell receptors from sequence repertoires. Proc Natl Acad Sci U S A (2012) 109:16161-6. doi:10.1073/pnas.1212755109
50. Hall MA, Reid JL, Lanchbury JS. The distribution of human TCR junctional region lengths shifts with age in both CD4 and CD8 T cells. Int Immunol (1998) 10:1407-19. doi:10.1093/intimm/10.10.1407
51. Jonsson AM, Uzunel M, Gotherstrom C, Papadogiannakis N, Westgren M. Maternal microchimerism in human fetal tissues. Am J Obstet Gynecol (2008) 198(325):e321-6.
52. Burlingham WJ, Nelson JL. Microchimerism in cord blood: mother as anticancer drug. Proc Natl Acad Sci U S A (2012) 109:2190-1. doi:10.1073/pnas.1120857109
53. Wienecke J, Hebel K, Hegel KJ, Pierau M, Brune T, Reinhold D, et al. Pro-inflammatory effector Th cells transmigrate through anti-inflammatory environments into the murine fetus. Placenta (2012) 33:39-46. doi:10.1016/j.placenta.2011.10.014
54. Haynes BF, Martin ME, Kay HH, Kurtzberg J. Early events in human T cell ontogeny. Phenotypic characterization and immunohistologic localization of T cell precursors in early human fetal tissues. J Exp Med (1988) 168:1061-80. doi:10.1084/jem.168.3.1061
55. Gadi VK. Fetal microchimerism in breast from women with and without breast cancer. Breast Cancer Res Treat (2010) 121:241-4. doi:10.1007/s10549-009-0548-1
56. Fugazzola L, Cirello V, Beck-Peccoz P. Fetal microchimerism as an explanation of disease. Nat Rev Endocrinol (2011) 7:89-97. doi:10.1038/nrendo.2010.216
57. Willer CJ, Sadovnick AD, Ebers GC. Microchimerism in autoimmunity and transplantation: potential relevance to multiple sclerosis. J Neuroimmunol (2002) 126:126-33. doi:10.1016/S0165-5728(02)00048-6
58. Adams KM, Nelson JL. Microchimerism: an investigative frontier in autoimmunity and transplantation. JAMA (2004) 291:1127-31. doi:10.1001/jama.291.9.1127
59. Lambert NC, Erickson TD, Yan Z, Pang JM, Guthrie KA, Furst DE, et al. Quantification of maternal microchimerism by HLA-specific real-time polymerase chain reaction: studies of healthy women and women with scleroderma. Arthritis Rheum (2004) 50:906-14. doi:10.1002/art.20200
60. Naumova EN, Gorski J, Naumov YN. Two compensatory pathways maintain long-term stability and diversity in CD8 T cell memory repertoires. J Immunol (2009) 183:2851-8. doi:10.4049/jimmunol.0900162
61. den Braber I, Mugwagwa T, Vrisekoop N, Westera L, Mogling R, De Boer AB, et al. Maintenance of peripheral naive T cells is sustained by thymus output in mice but not humans. Immunity (2012) 36:288-97. doi:10.1016/j.immuni.2012.02.006
62. Turchaninova MA, Britanova OV, Bolotin DA, Shugay M, Putintseva EV, Staroverov DB, et al. Pairing of T-cell receptor chains via emulsion PCR. Eur J Immunol (2013) 43(9):2507-15. doi:10.1002/eji.201343453